TrialCell reports. Medicine2025

Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer.

Daria Afenteva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.